Stock Yards Bank & Trust Co. Has $2.21 Million Position in Humana Inc. (NYSE:HUM)

Stock Yards Bank & Trust Co. reduced its position in shares of Humana Inc. (NYSE:HUM) by 8.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,332 shares of the insurance provider’s stock after selling 735 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Humana were worth $2,205,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Pullen Investment Management LLC acquired a new stake in Humana during the 1st quarter valued at $403,000. Fifth Third Bancorp raised its stake in Humana by 14.4% during the 1st quarter. Fifth Third Bancorp now owns 8,228 shares of the insurance provider’s stock valued at $2,177,000 after purchasing an additional 1,034 shares during the period. CX Institutional acquired a new stake in Humana during the 1st quarter valued at $213,000. Assenagon Asset Management S.A. raised its stake in Humana by 8.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 5,378 shares of the insurance provider’s stock valued at $1,423,000 after purchasing an additional 409 shares during the period. Finally, Handelsbanken Fonder AB grew its holdings in shares of Humana by 3.4% during the 1st quarter. Handelsbanken Fonder AB now owns 30,005 shares of the insurance provider’s stock valued at $7,939,000 after acquiring an additional 978 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HUM. Robert W. Baird boosted their price target on shares of Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, April 15th. Raymond James upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a report on Thursday, May 1st. Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a report on Thursday, May 1st. Guggenheim began coverage on shares of Humana in a report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price target on the stock. Finally, Barclays lowered their price target on shares of Humana from $273.00 to $268.00 and set an “equal weight” rating on the stock in a report on Thursday. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average price target of $284.24.

Humana Stock Down 0.0%

Humana stock opened at $234.87 on Friday. The firm has a market cap of $28.35 billion, a price-to-earnings ratio of 23.60, a P/E/G ratio of 2.05 and a beta of 0.43. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The firm has a fifty day moving average price of $250.43 and a two-hundred day moving average price of $262.65.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.23 EPS. As a group, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date of this dividend is Friday, June 27th. Humana’s dividend payout ratio is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.